logo

For the Inventor, By the Inventor

Fremont, CA, United States of America

Verseon Corporation

Calculating rank
USPTO Granted Patents = 15

% Expired Patents = 26.7



Forward Citations = 58

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal David B Kita (11 out of 26 patents)

silverMedal Kevin Michael Short (10 out of 11 patents)

bronzeMedal Son Minh Pham (9 out of 9 patents)

4.  David Charles Williams (8 out of 9 patents)

5.  Somalee Datta (5 out of 6 patents)

6.  Adityo Prakash (5 out of 40 patents)

7.  Eniko Fodor (5 out of 22 patents)

8.  Maria De Los Angeles Estiarte-Martinez (2 out of 3 patents)

9.  Timothy Philip Shiau (1 out of 1 patent)

10.  Sachin Ahuja (1 out of 5 patents)

11.  David Ben Kita (0 patent)

12.  Kita David (0 patent)

13.  Fodor Eniko (0 patent)

14.  Prakash Adityo (0 patent)


15 patents:

1. 10653674 - Multisubstituted aromatic compounds as inhibitors of thrombin (2020-05-19),
2. 10532995 - Substituted pyrazole compounds as serine protease inhibitors (2020-01-14),
3. 10251872 - Multisubstituted aromatic compounds as serine protease inhibitors (2019-04-09),
4. 10189810 - Pyrazolyl-substituted pyridone compounds as serine protease inhibitors (2019-01-29),
5. 10058541 - Multisubstituted aromatic compounds as serine protease inhibitors (2018-08-28),
6. 9963440 - Multisubstituted aromatic compounds as inhibitors of thrombin (2018-05-08),
7. 9951025 - Halogenopyrazoles as inhibitors of thrombin (2018-04-24),
8. 9687479 - Multisubstituted aromatic compounds as serine protease inhibitors (2017-06-27),
9. 9533970 - Multisubstituted aromatic compounds as serine protease inhibitors (2017-01-03),
10. 9533967 - Multisubstituted aromatic compounds as inhibitors of thrombin (2017-01-03),
11. 9317664 - Method and device for partitioning a molecule (2016-04-19),
12. 8036867 - Method and apparatus for analysis of molecular configurations and combinations (2011-10-11),
13. 7890313 - Method and apparatus for analysis of molecular combination based on computations of shape complementarity using basis expansions (2011-02-15),
14. 7751988 - Lead molecule cross-reaction prediction and optimization system (2010-07-06),
15. 6970790 - Method and apparatus for analysis of molecular combination based on computational estimation of electrostatic affinity using basis expansions (2005-11-29),
Company Overview
Verseon Corporation is a biotechnology firm based in Fremont, California, specializing in the development of innovative therapeutics. The company leverages advanced computational methods and proprietary drug discovery platforms to create novel treatments for various diseases, including cardiovascular and metabolic disorders. Verseon focuses on integrating technology with biology to enhance the efficiency of drug development, aiming to address unmet medical needs through its cutting-edge research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

15 Patents

#130 in Fremont, CA

#5,037 in California

#21,085 in US

#39,991 in the World

Fremont, CA (US)
Fremont, CA, United States of America

Verseon Corporation

Forward Citations = 58

10 inventors:

goldMedal David B Kita (11 out of 26 patents)

silverMedal Kevin Michael Short (10 out of 11 patents)

bronzeMedal Son Minh Pham (9 out of 9 patents)

4.  David Charles Williams (8 out of 9 patents)

5.  Somalee Datta (5 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Verseon Corporation. Retrieved from https://idiyas.com/company/verseon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…